Drug Farm has successfully closed its D-round Series A funding, securing $55 million. The round was co-led by Shanghai Pudong Leading Area Investment Center and Shanghai Puxing Collaborative Private Equity Partnership, with participation from multiple other investors including existing ones. The company plans to use the funds to advance its clinical and preclinical research pipelines, accelerate global development, bolster regulatory efforts, and expand its R&D capabilities. AI
RANK_REASON Significant funding round for a company in the pharmaceutical R&D sector. [lever_c_demoted from significant: ic=1 ai=0.0]
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
